论文部分内容阅读
临床精神药理学是一门发展迅速的学科,精神药物的药物不良反应监测、药动学研究、全球性的临床试验以及生物标记物的研究在我国也得到了相应的发展,这些发展为我国精神药物新药研发提供了相应的基础。本文回顾历史,强调本学科药品临床实验管理规范、医学伦理学及遗传药理学的发展,总结了“十五”的建设成果,并展望其发展前景。
Clinical psychopharmacology is a rapid development of the discipline, psychotropic substances adverse drug reactions monitoring, pharmacokinetic studies, global clinical trials and biomarkers in our country has also been the corresponding development of these developments for the spirit of our country Drug drug development provides the appropriate basis. This article reviews the history, emphasizes the development of clinical experimental management standard, medical ethics and genetic pharmacology, summarizes the construction achievements of “fifteen ” and looks forward to its development prospects.